Nektar Therapeutics Insider Transactions
Nektar Therapeutics Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Zalevsky Jonathan
Chief R&D Officer |
Sell | 51,115 @ $0.94 | $48,048 | 326,904 | 12/19/2024 | 12/20/2024 | |
|
ROBIN HOWARD W
CEO |
Sell | 85,035 @ $0.99 | $84,185 | 1,110,675 | 12/18/2024 | 12/19/2024 | |
|
ROBIN HOWARD W
CEO |
Sell | 46,995 @ $1.01 | $47,465 | 1,195,710 | 12/17/2024 | 12/19/2024 | |
|
Zalevsky Jonathan
Chief R&D Officer |
Sell | 7,785 @ $1.01 | $7,863 | 243,019 | 11/19/2024 | 11/20/2024 | |
|
Wilson Mark Andrew
Chief Legal Officer |
Sell | 6,407 @ $1.01 | $6,471 | 218,856 | 11/19/2024 | 11/20/2024 | |
|
ROBIN HOWARD W
CEO |
Sell | 16,278 @ $1.01 | $16,441 | 832,080 | 11/19/2024 | 11/20/2024 | |
|
Zalevsky Jonathan
Chief R&D Officer |
Sell | 6,866 @ $1.28 | $8,788 | 250,804 | 08/19/2024 | 08/20/2024 | |
|
Wilson Mark Andrew
Chief Legal Officer |
Sell | 5,651 @ $1.28 | $7,233 | 225,263 | 08/19/2024 | 08/20/2024 | |
|
ROBIN HOWARD W
CEO |
Sell | 14,881 @ $1.28 | $19,048 | 848,358 | 08/19/2024 | 08/20/2024 | |
|
CHESS ROBERT
Director |
Sell | 19,500 @ $1.20 | $23,400 | 255,273 | 06/14/2024 | 06/14/2024 | |
|
Wilson Mark Andrew
Chief Legal Officer |
Sell | 6,260 @ $1.75 | $10,955 | 230,414 | 05/17/2024 | 05/20/2024 | |
|
Zalevsky Jonathan
Chief R&D Officer |
Sell | 7,355 @ $1.75 | $12,871 | 257,670 | 05/17/2024 | 05/20/2024 | |
|
ROBIN HOWARD W
CEO |
Sell | 16,650 @ $1.75 | $29,138 | 863,239 | 05/17/2024 | 05/20/2024 | |
|
Deep Track Capital, LP
10 percent owner |
Sell | 56,000 @ $1.78 | $99,630 | 18,344,000 | 05/10/2024 | 05/13/2024 | |
|
Zalevsky Jonathan
Chief R&D Officer |
Sell | 9,014 @ $0.68 | $6,130 | 265,025 | 02/20/2024 | 02/22/2024 | |
|
Wilson Mark Andrew
Chief Legal Officer |
Sell | 7,606 @ $0.68 | $5,172 | 236,674 | 02/20/2024 | 02/22/2024 | |
|
ROBIN HOWARD W
CEO |
Sell | 20,033 @ $0.68 | $13,622 | 879,889 | 02/20/2024 | 02/22/2024 | |
|
Zalevsky Jonathan
Chief R&D Officer |
Sell | 9,646 @ $0.49 | $4,727 | 274,039 | 11/17/2023 | 11/20/2023 | |
|
Wilson Mark Andrew
Chief Legal Officer |
Sell | 7,179 @ $0.49 | $3,518 | 243,780 | 11/17/2023 | 11/20/2023 | |
|
ROBIN HOWARD W
CEO |
Sell | 19,877 @ $0.49 | $9,740 | 899,922 | 11/17/2023 | 11/20/2023 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Nektar Therapeutics FAQ's
The list of insiders at Nektar Therapeutics includes Deep Track Capital, LP, ROBIN HOWARD W, Zalevsky Jonathan, Wilson Mark Andrew, CHESS ROBERT.
Insiders have sold a total of 346,778 Nektar Therapeutics shares in the last 12 months for a total of 421,535 sold.
The following insiders have sold Nektar Therapeutics shares in the last 12 months: Deep Track Capital, LP ($99,630), ROBIN HOWARD W ($196,276), Zalevsky Jonathan ($77,571), Wilson Mark Andrew ($24,659), CHESS ROBERT ($23,400),